feed,title,long_url,short_url
🔐MarketWatch,Protagonist Therapeutics shares slid after sharing Phase 2 data for its experimental ulcerative colitis treatment,http://www.marketwatch.com/news/story/protagonist-therapeutics-shares-slid-after/story.aspx?guid=%7B19413884%2D2F81%2D4EBE%2DB0A5%2D0C4F8BE7F328%7D&siteid=rss,https://on.mktw.net/3kbu8bl
